Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $730 at BMO Capital Following LAG-3 Miss

May 18, 2026 7:40 AM
(Updated - May 18, 2026 9:39 AM EDT)

BMO Capital analyst Evan David Seigerman lowered the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change